Ruzasvir

CAS No. 1613081-64-3

Ruzasvir( MK-8408 | MK 8408 | MK8408 )

Catalog No. M12336 CAS No. 1613081-64-3

A potent, pan-genotype HCV NS5A inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 432 In Stock
10MG 618 In Stock
25MG 972 In Stock
50MG 1332 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ruzasvir
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, pan-genotype HCV NS5A inhibitor.
  • Description
    A potent, pan-genotype HCV NS5A inhibitor with replicon EC90 of 0.003, 0.016, 0.067, 0.036, 0.007, and 0.007 nM for GT1a, GT1a L31V, GT1a Y93H, GT2b, GT3a, and Gt4a, respectively.HCV Infection Phase 2 Clinical.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    MK-8408 | MK 8408 | MK8408
  • Pathway
    Microbiology/Virology
  • Target
    HCV
  • Recptor
    HCV
  • Research Area
    Infection
  • Indication
    HCV Infection

Chemical Information

  • CAS Number
    1613081-64-3
  • Formula Weight
    947.1
  • Molecular Formula
    C49H55FN10O7S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    FC1=C(C(N2[C@H](C3=CN=C(C4CC4)S3)O5)=CC6=C2C=CC(C7=CN=C(C8N(C(C(NC(OC)=O)C(C)C)=O)CCC8)N7)=C6)C5=CC(C9=CN=C([C@H]%10N(C(C(NC(OC)=O)C(C)C)=O)CCC%10)N9)=C1
  • Chemical Name
    Dimethyl N,N'-([(6S)-6-(2-cyclopropyl-1,3-thiazol-5-yl)-1-fluoro-6H-indolo[1,2-c][1,3]benzoxazine-3,10-diyl]bis{(1H-imidazole-4,2-diyl)[(2S)-pyrrolidine-2,1- diyl][(2S)-3-methyl-1-oxobutane-1,2-diyl]})dicarbamate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Tong L, et al. J Med Chem. 2017 Jan 12;60(1):290-306. 2. Wyles D, et al. Hepatology. 2017 Dec;66(6):1794-1804. 3. Lawitz E, et al. Lancet Gastroenterol Hepatol. 2017 Nov;2(11):814-823.
molnova catalog
related products
  • Simeprevir

    A potent, orally available inhibitor of HCV NS3/4A protease with Ki of 0.36 nM, replicon EC50 of 7.8 nM.

  • Danoprevir

    A potent, highly selective, orally available, peptidomimetic HCV NS3/4A protease inhibitor with IC50 of 0.2-0.4 nM (GT1a, 1b, 4, 5 and 6), 1.6 nM (GT2b).

  • MK-8325

    MK-8325 is a potent, selective pan-genotype HCV NS5A inhibitor with IC50 of 15, 1 and 3 pM for GT1a, GT1b and GT2a, respectively.